Cassie Jung

Executive

Chief Operating Officer

Insider activity · 24 months0 buys1 saleCumulative net flow

Nov 24 · 0 buys · 1 saleDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (1 ops.)

€205

Latest filing published 08 Sept 2026 for Aquestive Therapeutics, Inc., €3,798. Read the official filing

Filing timeline

BuySale

Cassie Jung

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Cassie Jung: trading record in brief

Cassie Jung is a declared insider of Aquestive Therapeutics, Inc. (senior executive), with filings sourced from SEC (Form 4). We count 10 filings; the first trade dates from 9 March 2023 and the latest from 3 September 2026.

The open-market record consists of 1 sale worth €205, with no purchase. The rest of the record consists of 7 share grants and 2 option exercises.

On 8 September 2026 came the latest disclosure, a share grant for €3,798 in Aquestive Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.